165 related articles for article (PubMed ID: 18467696)
1. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.
Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T
Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696
[TBL] [Abstract][Full Text] [Related]
2. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
4. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
Kuiken T; Fouchier RA; Schutten M; Rimmelzwaan GF; van Amerongen G; van Riel D; Laman JD; de Jong T; van Doornum G; Lim W; Ling AE; Chan PK; Tam JS; Zambon MC; Gopal R; Drosten C; van der Werf S; Escriou N; Manuguerra JC; Stöhr K; Peiris JS; Osterhaus AD
Lancet; 2003 Jul; 362(9380):263-70. PubMed ID: 12892955
[TBL] [Abstract][Full Text] [Related]
5. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS.
Nicholls JM; Butany J; Poon LL; Chan KH; Beh SL; Poutanen S; Peiris JS; Wong M
PLoS Med; 2006 Feb; 3(2):e27. PubMed ID: 16379499
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.
Baas T; Taubenberger JK; Chong PY; Chui P; Katze MG
J Interferon Cytokine Res; 2006 May; 26(5):309-17. PubMed ID: 16689659
[TBL] [Abstract][Full Text] [Related]
7. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.
Yoshikawa T; Hill TE; Yoshikawa N; Popov VL; Galindo CL; Garner HR; Peters CJ; Tseng CT
PLoS One; 2010 Jan; 5(1):e8729. PubMed ID: 20090954
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan.
Shieh WJ; Hsiao CH; Paddock CD; Guarner J; Goldsmith CS; Tatti K; Packard M; Mueller L; Wu MZ; Rollin P; Su IJ; Zaki SR
Hum Pathol; 2005 Mar; 36(3):303-9. PubMed ID: 15791576
[TBL] [Abstract][Full Text] [Related]
9. Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques.
Rockx B; Feldmann F; Brining D; Gardner D; LaCasse R; Kercher L; Long D; Rosenke R; Virtaneva K; Sturdevant DE; Porcella SF; Mattoon J; Parnell M; Baric RS; Feldmann H
PLoS One; 2011 Apr; 6(4):e18558. PubMed ID: 21533129
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell death during infection by the severe acute respiratory syndrome coronavirus and other coronaviruses.
Tan YJ; Lim SG; Hong W
Cell Microbiol; 2007 Nov; 9(11):2552-61. PubMed ID: 17714515
[TBL] [Abstract][Full Text] [Related]
11. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
Youk J; Kim T; Evans KV; Jeong YI; Hur Y; Hong SP; Kim JH; Yi K; Kim SY; Na KJ; Bleazard T; Kim HM; Fellows M; Mahbubani KT; Saeb-Parsy K; Kim SY; Kim YT; Koh GY; Choi BS; Ju YS; Lee JH
Cell Stem Cell; 2020 Dec; 27(6):905-919.e10. PubMed ID: 33142113
[TBL] [Abstract][Full Text] [Related]
12. Murine Alveolar Macrophages Rapidly Accumulate Intranasally Administered SARS-CoV-2 Spike Protein leading to Neutrophil Recruitment and Damage.
Park C; Hwang IY; Yan SL; Vimonpatranon S; Wei D; Van Ryk D; Girard A; Cicala C; Arthos J; Kehrl JH
bioRxiv; 2023 Dec; ():. PubMed ID: 37090605
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential.
Cui X; Chen W; Zhou H; Gong Y; Zhu B; Lv X; Guo H; Duan J; Zhou J; Marcon E; Ma H
Front Pharmacol; 2021; 12():664349. PubMed ID: 34163357
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome in children: a clue to better understanding the disease and advancing towards solutions.
Bermejo JF; Muñoz-Fernandez MA
Acta Paediatr; 2004 Jun; 93(6):856-7. PubMed ID: 15244243
[No Abstract] [Full Text] [Related]
15. Assessment of GO-Based Protein Interaction Affinities in the Large-Scale Human-Coronavirus Family Interactome.
Bandyopadhyay SS; Halder AK; Saha S; Chatterjee P; Nasipuri M; Basu S
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992133
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.
Keskinidou C; Vassiliou AG; Dimopoulou I; Kotanidou A; Orfanos SE
J Inflamm Res; 2022; 15():3501-3546. PubMed ID: 35734098
[TBL] [Abstract][Full Text] [Related]
17. Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.
Yasui F; Matsumoto Y; Yamamoto N; Sanada T; Honda T; Munakata T; Itoh Y; Kohara M
Sci Rep; 2022 Mar; 12(1):4150. PubMed ID: 35264719
[TBL] [Abstract][Full Text] [Related]
18. A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection.
Iwata-Yoshikawa N; Shiwa N; Sekizuka T; Sano K; Ainai A; Hemmi T; Kataoka M; Kuroda M; Hasegawa H; Suzuki T; Nagata N
Sci Adv; 2022 Jan; 8(1):eabh3827. PubMed ID: 34995117
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 on Children and Young Adults With Type 2 Diabetes: A Narrative Review With Emphasis on the Potential of Intermittent Fasting as a Preventive Strategy.
Elmajnoun HK; Faris ME; Uday S; Gorman S; Greening JE; Haris PI; Abu-Median AB
Front Nutr; 2021; 8():756413. PubMed ID: 34778345
[No Abstract] [Full Text] [Related]
20. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Idris A; Davis A; Supramaniam A; Acharya D; Kelly G; Tayyar Y; West N; Zhang P; McMillan CLD; Soemardy C; Ray R; O'Meally D; Scott TA; McMillan NAJ; Morris KV
Mol Ther; 2021 Jul; 29(7):2219-2226. PubMed ID: 33992805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
